Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma.
Yu-Yun ShaoNai-Yun SunYung-Ming JengYao-Ming WuChiun HsuChih-Hung HsuHey-Chi HsuAnn-Lii ChengZhong-Zhe LinPublished in: Cells (2021)
High Eg5 expression was associated with poor HCC prognosis. In vitro and in vivo evidence suggests that Eg5 may be a reasonable therapeutic target for HCC.